Microbiota regulate innate immune signaling and protective immunity against cancer
Changsheng Xing(University of Southern California), Rong‐Fu Wang(Houston Methodist), Zhao-Zhe Hao(Baylor College of Medicine), Adebusola Alagbala Ajibade(Houston Methodist), Chuntang Fu(University of Southern California), Peng Tan(Broad Institute), Motao Zhu(Nationwide Children's Hospital), Helen Y. Wang(University of Southern California), Jiahui Zhu(Hubei University of Technology), Tianhao Duan(University of Southern California), Lang Chen(Affiliated Hospital of Southwest Medical University), Mingjun Wang(Houston Methodist), Bingnan Yin(University of Southern California), Junjun Chu(Anhui University of Traditional Chinese Medicine), Wan-Jou Shen(Texas A&M Health Science Center), Xiao Yu(Huazhong Agricultural University)
Cited by 160
Related Papers
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
|Cancer Research|2008|2k
Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
|Frontiers in Immunology|2022|880
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
|Journal of Neuroinflammation|2019|746
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
|Science Translational Medicine|2015|541